LinkedIn founder Red Hoffman and Sidhartha Mukherji, Cancer Researcher and author of “Emperor of all diseases”, participated in establishing a drug discovery company that works in Amnesty International, You have Manas. The company, which will initially focus on breast cancer, prostate cancer, and lymphoma, raised $ 24.6 million of Hoffmann’s seed financing, General Kumalst, and Gariok.
The capital from Manas AI is diminished compared to some other startups trying to use artificial intelligence models to develop new drugs. Last year, Xaira, which she claimed was ready to start drug development, was launched billion dollars in initial financing. Treeline Biosciencees is another company that uses artificial intelligence to discover drugs and raised $ 422 million last year, I reported indpts.
Manas AI claims that she will desigate molecules with artificial intelligence, then test them in a wet laboratory, According to Hoffman, Hoffman said During his new book “Superagence”. Manas He says The cloud computing platform will be used by Microsoft, Microsoft Azure and Microsoft “Knowing the Deep District in Artificial Intelligence” to develop new drugs.
Hoffman has close ties to Microsoft, which captured his former company, LinkedIn, in a great deal in 2016.
